| |
|
|
| Name: |
MPM ONCOLOGY IMPACT MANAGEMENT LP |
| City: |
CAMBRIDGE |
| State: |
MA |
| Zip: |
02142 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
10 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
IOVA |
Iovance Biotherapeutics Inc |
2 |
- |
$10.68 |
$26,743,000 |
3,289,470 |
6.26% |
11,785,000 |
2,073 |
1.538 |
N/A |
|
|
GERN |
Geron Corporation |
4 |
- |
$3.90 |
$22,610,000 |
10,715,620 |
5.29% |
-100,000 |
3,139 |
3.132 |
Drug Manufacturers - ... |
|
|
MLTX |
Multisys Language Solutions... |
7 |
- |
$0.00 |
$17,789,000 |
294,576 |
4.16% |
1,020,000 |
386 |
0.717 |
N/A |
|
|
KRTX |
Karuna Therapeutics, Inc. |
9 |
- |
$0.00 |
$16,863,000 |
53,279 |
3.95% |
7,866,000 |
69 |
0.132 |
N/A |
|
|
INSM |
Insmed Inc |
10 |
- |
$24.93 |
$16,367,000 |
528,150 |
3.83% |
3,049,000 |
692 |
0.348 |
Biotechnology |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
11 |
- |
$32.48 |
$14,436,000 |
611,181 |
3.38% |
5,329,000 |
411 |
0.645 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
16 |
- |
$211.73 |
$9,466,000 |
40,910 |
2.21% |
3,499,000 |
51 |
0.247 |
Diagnostic Substances |
|
|
AVDL |
AVADEL Pharmaceuticals Plc |
18 |
- |
$15.99 |
$9,390,000 |
664,986 |
2.2% |
2,548,000 |
762 |
1.142 |
Drug Delivery |
|
|
MORF |
Morphic Holding, Inc. |
19 |
- |
$30.23 |
$9,350,000 |
323,742 |
2.19% |
4,768,000 |
123,742 |
0.841 |
N/A |
|
|
VKTX |
Viking Therapeutics, Inc. |
26 |
- |
$78.01 |
$6,054,000 |
325,284 |
1.42% |
2,456,000 |
284 |
0.446 |
N/A |
|
